Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorTORRES, Chloé
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorLAGADEC, Floriane
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorBASYUK, Eugenia
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorRECORDON-PINSON, Patricia
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorMÉTIFIOT, Mathieu
dc.date.accessioned2025-09-01T08:08:27Z
dc.date.available2025-09-01T08:08:27Z
dc.date.issued2025-08-20
dc.identifier.issn1999-4915en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/207542
dc.description.abstractEnIntegrase is a key protein during HIV-1 replication as it catalyzes the integration of viral DNA into the host DNA. After several decades of research, highly potent and selective active site inhibitors have emerged. The new challenge is now to develop molecules with an original mode of action, targeting integrase out of its catalytic site. During a previous study, we developed an in vitro assay to monitor the interaction between HIV-1 integrase and one of its cellular partners, GCN2. This AlphaLISA-based assay was validated as a platform for chemical modulator screening. In the present study, we used a library of natural products from the Developmental Therapeutics Program (NIH) to identify novel chemical leads. The best modulators were characterized and a structure-activity relationship study was initiated with a limited number of derivatives. We found that most inhibitors were tricylic or tetraclyclic molecules, with the most potent belonging to the anthracyclines/anthraquinones. Of note, several molecules exhibited interesting cellular activities and may be suitable for further optimization.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enHIV Integrase
dc.subject.enHumans
dc.subject.enHIV Integrase Inhibitors
dc.subject.enHIV-1
dc.subject.enStructure-Activity Relationship
dc.subject.enProtein Binding
dc.subject.enProtein Serine-Threonine Kinases
dc.subject.enVirus Replication
dc.title.enIsolation of New Chemical Modulators of the Interaction Between HIV-1 Integrase and the Cellular Restriction Factor GCN2.
dc.title.alternativeVirusesen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/v17081138en_US
dc.subject.halSciences du Vivant [q-bio]/Microbiologie et Parasitologieen_US
dc.identifier.pubmed40872851en_US
bordeaux.journalVirusesen_US
bordeaux.volume17en_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.issue8en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-05232491
hal.version1
hal.date.transferred2025-09-01T08:08:30Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Viruses&rft.date=2025-08-20&rft.volume=17&rft.issue=8&rft.eissn=1999-4915&rft.issn=1999-4915&rft.au=TORRES,%20Chlo%C3%A9&LAGADEC,%20Floriane&BASYUK,%20Eugenia&RECORDON-PINSON,%20Patricia&M%C3%89TIFIOT,%20Mathieu&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée